Trials / Unknown
UnknownNCT05363410
Micronutrient Supplement for Nurse Burnout
Quantifying the Effects of MagnéVie B6® on Stress and Burnout Among Nurses During the COVID-19 Pandemic: A Randomized Double Blind Placebo-Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- Sponsor
- Nutraceuticals Research Institute · Academic / Other
- Sex
- Female
- Age
- 20 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to confirm and quantify the ability of an 8-week intervention with a supplement containing magnesium citrate and vitamin B6 to reduce anxiety, stress, and burnout among nurses working full time in hospitals and urgent care centers during the COVID-19 Pandemic.
Detailed description
After being informed about the study and potential risks, all participants woh meet the eligibility criteria will provide written informed consent. They will then be randomized in a 1:1 ratio to either MagnéVie B6® or a placebo group. The assigned product will be consumed 3 times daily for 8 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | MagnéVie B6® | micronutrient supplement |
| OTHER | Placebo | placebo supplement |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2022-09-30
- Completion
- 2023-04-30
- First posted
- 2022-05-05
- Last updated
- 2022-05-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05363410. Inclusion in this directory is not an endorsement.